🔎 Trials Near Me

Akèy › Sarkom tisi mou › Illinois › Chicago

Etid klinik pou Sarkom tisi mou nan Chicago, IL

7 etid pou Sarkom tisi mou ap chèche patisipan nan sit nan ak bò kote Chicago (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors

Ap rekriteFaz 1/2
  • University Chicago Medicine, Chicago
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT05732831

Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma

Ap rekriteFaz 1
  • University of Chicago Comprehensive Cancer Center, Chicago
Laj 18 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT05711615

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Mount Sinai Hospital Medical Center, Chicago
  • John H Stroger Jr Hospital of Cook County, Chicago
  • University of Illinois, Chicago
  • ak 1 plis
Laj 40 a 75 · Tout sèks · Mizajou Sep 2, 2026 · NCT05334069

NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

Ap rekriteFaz 1/2
  • Lurie Children's Hospital of Chicago, Chicago
Jiska laj 30 · Tout sèks · Mizajou Aug 3, 2026 · NCT06239272

Safety and Feasibility of Intraoperative Visualization With Cytalux in Children

Ap rekriteFaz 1
  • Ann & Robert H. Lurie Children's Hospital, Chicago
Laj 6 a 17 · Tout sèks · Mizajou Jun 5, 2026 · NCT06235125

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

Ap rekriteFaz 1/2
  • University of Chicago, Chicago
Laj 12 ak plis · Tout sèks · Mizajou May 27, 2026 · NCT03093116

Specimen and Data Study for Ovarian Cancer Early Detection and Prevention

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago
Laj 18 a 80 · Fanm · Mizajou Feb 28, 2025 · NCT00005095

Etid Sarkom tisi mou nan lòt vil

Lòt etid nan Chicago

Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.